Studying the Clinical Trial Experiences of Patients With Mesothelioma
Launched by POWER LIFE SCIENCES INC. · Apr 6, 2023
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand the experiences of patients with mesothelioma who participate in medical research studies. The researchers want to find out what might make it hard for patients to join or stay in these studies. By examining information from different groups of people, they hope to identify trends that could help improve the experience for future mesothelioma patients in clinical trials.
To be eligible for this study, participants must be at least 18 years old and have been diagnosed with mesothelioma by a doctor. They should be willing to follow the study schedule, which includes attending visits and undergoing certain tests. However, the study cannot include pregnant or breastfeeding women and those with significant issues that could affect their ability to participate safely. This trial is not yet recruiting participants, but it aims to create a better environment for those who will take part in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must have a medical diagnosis of mesothelioma that has been confirmed by a physician.
- • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
- • Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
- Exclusion Criteria:
- • Pregnant or lactating woman
- • Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent.
- • Known medical condition that, in the investigator's opinion, would increase the risk associated with study participation or study drug(s) administration or interfere with the interpretation of safety results
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported